Larimar Therapeutics LRMR
NASDAQ LRMR
$3.14 -0.03 (-0.95%)
At close: Sep 29, 2026 · 4:00 PM EDT

Larimar Therapeutics (LRMR) Cash from Restructuring (2019 - 2020)

Updated

Larimar Therapeutics' Cash from Restructuring came in at -$1.73 million for Q1 2020.

Analysis

Larimar Therapeutics (LRMR) Cash from Restructuring (2019 - 2020) Analysis & Trends

For FY2019, Larimar Therapeutics' Cash from Restructuring was $2.71 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Larimar Therapeutics 329.31 Mn -277.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 -1.73 Mn
Dec 31, 2019 -910,000.00
API Access

Larimar Therapeutics Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=LRMR&period=max&api_key=YOUR_API_KEY